110 - Infectious Disease Consulting for Businesses During COVID-19: Tales from the Front Line

Friday, October 1, 2021

4:15 PM - 5:30 PM EDT

Moderator(s)

Daniel Morgan, MD, MS

Professor of Epidemiology and Public Health and Infectious Disease
School of Medicine
University of Maryland
Baltimore, MD, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sonali Advani, MBBS, MPH

Assistant Professor of Medicine, Co-Medical Director of DICON
Infectious Diseases
Duke University School of Medicine, Duke Infection Control Outreach Network
Durham, North Carolina, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

David Aronoff, MD

Chair, Department of Medicine
Indiana University School of Medicine
Indianapolis, IN, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jeanne Marrazzo, MD MPH

Professor of Medicine & Division Director
University of Alabama at Birmingham

Gilead (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member
Anthony Harris, MD, MPH

Professor
University of Maryland
Baltimore, MD, United States

Merck (Individual(s) Involved: Self): Grant/Research Support; Netflix (Individual(s) Involved: Self): Consultant; UpToDate (Individual(s) Involved: Self): Infection control section editor. Author., Other Financial or Material Support

Participants should be aware of the following financial/non-financial relationships:

Daniel Morgan, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Sonali D. Advani, MBBS, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

David Aronoff, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jeanne Marrazzo, MD MPH: Gilead (Individual(s) Involved: Self): Advisor or Review Panel member; Merck (Individual(s) Involved: Self): Advisor or Review Panel member

Anthony Harris, MD, MPH: Merck (Individual(s) Involved: Self): Grant/Research Support; Netflix (Individual(s) Involved: Self): Consultant; UpToDate (Individual(s) Involved: Self): Infection control section editor. Author., Other Financial or Material Support

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain the demands of consulting for COVID-19 prevention
discuss the different demands on infectious disease physicians for consulting
describe various scenarios from their peers

Presentations:

COVID-19 Consulting for Airlines & Museums
Speaker: David Aronoff, MD – Vanderbilt University Medical Center
COVID-19 Consulting for Sports
Speaker: Jeanne Marrazzo, MD MPH – University of Alabama at Birmingham
COVID-19 Consulting for the Entertainment Industry
Speaker: Anthony Harris, MD, MPH – University of Maryland